Crossject S.A [ALCJ] vs Spineway S.A [ALSPW] Detailed Stock Comparison
Crossject S.A
Euronext
Loading...
Spineway S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Crossject S.A wins in 5 metrics, Spineway S.A wins in 10 metrics, with 0 ties. Spineway S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crossject S.A | Spineway S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 0.02 | N/A |
| Price-to-Book Ratio | N/A | 0.18 | N/A |
| Debt-to-Equity Ratio | -7.88 | 6.46 | Crossject S.A |
| PEG Ratio | 7.65 | 4.26 | Spineway S.A |
| EV/EBITDA | -7.59 | -2.08 | Crossject S.A |
| Profit Margin (TTM) | 0.00% | -16.10% | Crossject S.A |
| Operating Margin (TTM) | -246.47% | -20.87% | Spineway S.A |
| Return on Equity | 478.68% | -8.42% | Crossject S.A |
| Return on Assets (TTM) | -26.91% | -2.79% | Spineway S.A |
| Free Cash Flow (TTM) | $-11.48M | $-3.27M | Spineway S.A |
| 1-Year Return | -28.51% | 8.33% | Spineway S.A |
| Price-to-Sales Ratio (TTM) | 20.76 | 0.38 | Spineway S.A |
| Enterprise Value | $91.40M | $1.89M | Crossject S.A |
| EV/Revenue Ratio | 22.21 | 0.16 | Spineway S.A |
| Revenue per Share (TTM) | $0 | $1 | Spineway S.A |
| Earnings per Share (Diluted) | $-0.28 | $0.00 | Spineway S.A |
| Beta (Stock Volatility) | 0.84 | 0.80 | Spineway S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Crossject S.A vs Spineway S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crossject S.A | -0.12% | 2.44% | 4.35% | -1.18% | -6.67% | -25.00% |
| Spineway S.A | 0.78% | 0.00% | 8.33% | 8.33% | 8.33% | 44.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crossject S.A | -28.51% | -56.70% | -55.79% | -73.79% | -85.44% | -85.44% |
| Spineway S.A | 8.33% | 8.33% | 8.33% | 8.33% | 8.33% | 8.33% |
Performance & Financial Health Analysis: Crossject S.A vs Spineway S.A
| Metric | ALCJ | ALSPW |
|---|---|---|
| Market Information | ||
| Market Cap | €85.42M | €4.54M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 156,566 | 364,260 |
| 90 Day Avg. Volume | 186,589 | 563,721 |
| Last Close | €1.68 | €0.13 |
| 52 Week Range | €0.72 - €2.75 | €0.07 - €0.65 |
| % from 52W High | -39.05% | -80.03% |
| All-Time High | €13.09 (Feb 24, 2014) | €0.15 (Jun 10, 2025) |
| % from All-Time High | -87.17% | -13.33% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 2.27% | -0.14% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | -0.16% |
| Operating Margin (TTM) | -2.46% | -0.21% |
| Return on Equity (TTM) | 4.79% | -0.08% |
| Debt to Equity (MRQ) | -7.88 | 6.46 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.06 | €0.70 |
| Cash per Share (MRQ) | €0.15 | €0.12 |
| Operating Cash Flow (TTM) | €-7,958,000 | €580,000 |
| Levered Free Cash Flow (TTM) | €-8,143,750 | €121,250 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Crossject S.A vs Spineway S.A
| Metric | ALCJ | ALSPW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 0.02 |
| Forward P/E | 7.65 | 4.26 |
| PEG Ratio | 7.65 | 4.26 |
| Price to Sales (TTM) | 20.76 | 0.38 |
| Price to Book (MRQ) | N/A | 0.18 |
| Market Capitalization | ||
| Market Capitalization | €85.42M | €4.54M |
| Enterprise Value | €91.40M | €1.89M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.21 | 0.16 |
| Enterprise to EBITDA | -7.59 | -2.08 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.80 |
| Book Value per Share (MRQ) | €-0.06 | €0.70 |
Financial Statements Comparison: Crossject S.A vs Spineway S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALCJ | ALSPW |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALCJ | ALSPW |
|---|---|---|
| Cash & Equivalents | €7.04M | €4.52M |
| Total Current Assets | €15.88M | €13.89M |
| Total Current Liabilities | €6.87M | €4.23M |
| Long-Term Debt | €18.35M | €1.66M |
| Total Shareholders Equity | €-2.67M | €24.24M |
| Retained Earnings | €-15.39M | €-3.87M |
| Property, Plant & Equipment | €2.13M | €5.93M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALCJ | ALSPW |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALCJ | ALSPW |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 156,566 | 364,260 |
| Average Daily Volume (90 Day) | 186,589 | 563,721 |
| Shares Outstanding | 45.40M | 19.91M |
| Float Shares | 33.30M | N/A |
| % Held by Insiders | 0.20% | 0.00% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Crossject S.A vs Spineway S.A
| Metric | ALCJ | ALSPW |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |